会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMPUTATIONAL DESIGN OF A WATER-SOLUBLE ANALOG OF A PROTEIN, SUCH AS PHOSPHOLAMBAN AND POTASSIUM CHANNEL KCSA
    • 蛋白质水溶性模拟物的计算设计,如磷酰胺和钾通道KCSA
    • WO2004065363A2
    • 2004-08-05
    • PCT/US2004/001317
    • 2004-01-21
    • THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIASAVEN, Jeffrery, G.DEGRADO, William, F.SLOVIC, Avram, M.SUMMA, Christopher, M.KONO, Hidetoshi
    • SAVEN, Jeffrery, G.DEGRADO, William, F.SLOVIC, Avram, M.SUMMA, Christopher, M.KONO, Hidetoshi
    • C07D
    • G06F19/16G06F19/18
    • Membrane proteins and water-soluble proteins share a similar core. This similarity suggests that it should be possible to water-solubilize membrane proteins by mutating only their lipid-exposed residues. Computational tools and methods are disclosed herein that can be used to design water-soluble variants of helical membrane proteins, using the pentameric phospholamban (PLB) and potassium channel KcsA as models. To water-solublize PLB, the membrane-exposed positions were changed to polar or charged amino acids, while the putative core was left unaltered. We generated water-soluble phospholamban (WSPLB), and compared its properties to its predecessor PLB. As a probe of the correctness of the fold of the water soluble KcsA, the computationally designed proteins contain an agitoxin-2 binding site from a mammalian homologue of the channel. The resulting proteins express in high yield in E. coli and share the intended functional and structural properties with KcsA, including secondary structure, tetrameric quaternary structure, and tight, specific binding to both agitoxin2 and a small molecule channel blocker.
    • 膜蛋白和水溶性蛋白质共享相似的核心。 这种相似性表明,应该可以通过仅突变其暴露于脂质的残留物来水溶性膜蛋白。 本文公开了可用于设计螺旋膜蛋白质的水溶性变体的计算工具和方法,其使用五聚磷酸甘油(PLB)和钾通道KcsA作为模型。 为了水解PLB,将膜暴露的位置改为极性或带电荷的氨基酸,而假定的核心保持不变。 我们产生了水溶性磷脂蛋白(WSPLB),并将其性能与其前身PLB进行了比较。 作为水溶性KcsA的倍数的正确性的探针,计算设计的蛋白质含有来自哺乳动物同源物的通道的搅拌毒素-2结合位点。 所得蛋白质在大肠杆菌中以高产率表达,并且与KcsA共享预期的功能和结构性质,包括二级结构,四聚体四级结构,以及紧密的,特异性结合于vibroxin2和小分子通道阻断剂。